Curiox fetches $15 mln Series B

Singapore-based Curiox Biosystems, a bioinstrumentation company, has raised $15 million in Series B funding. The investors included KB Investment, IMM Investment, QUAD Investment, HB Investment, DAYLI Investment and SV Investment.

17 October 2019•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles